Global Market Study on Dengue Testing: Asia Pacific to Hold Dominant Revenue Share over 2017 – 2025
Read the full report: https://www.reportlinker.com/p05429841
There is growing consensus among healthcare providers that the current fee-for-services payment mechanism needs an overhaul.While fee-for-services is the pervasive method of billing patients, alternative processes, such as capitation and pay-for-performance are also being considered.
We anticipate fee-for-services to be supplemented by capitation and pay-for-performance in the future.In addition to charging patients for screening and doctor visits, pay-for-performance can lead to higher quality of care, as other essential tasks will also be billed.
It may lead to an increase in healthcare costs, with the promise that quality of care will go up.
The healthcare system is in a phase where access to capital is constantly diminishing.Big spends are rare and there is increasing uncertainty among borrowers about their ability to repay loans and funding.
Healthcare institutions are either postponing large capital-intensive projects or allocating resources to specialty areas that offer a high ROI.Cash-constraints will result into an increase in mergers and acquisitions and lead to fundraising from healthcare providers.
However, as only a select few will qualify for an acquisition or funding, the effects of cash-crunch will be palpable in this sector.
Healthcare providers and insurers are aware of the rapidly increasingly population and their growing healthcare needs. The impact is more palpable in the
Healthcare providers and insurers are aware that emerging markets remain crucial to their long-term prospects.In a bid to consolidate their position in key emerging markets, such as
Spending on healthcare services is expected to grow at a higher pace in
Current expenditure on health, % of gross domestic product
Current expenditure on health, per capita, US$ purchasing power parities (current prices, current PPPs)
Annual growth rate of current expenditure on health, per capita, in real terms
Out-of-pocket expenditure, % of current expenditure on healthcare services
Out-of-pocket expenditure, per capita, US$ purchasing power parity (current prices, current PPPs)
Physicians, Density per 1000 population (head counts)
Nurses, Density per 1000 population (head counts)
Research Methodology
We conduct about 45-60 min duration detailed interviews with product manufacturers; apart from this we also collect market feedback from industry experts.To validate this data, we interact with senior panel members having more than 10 years of experience in relevant field.
The panel members help in validating the findings and fill the gaps if any.In addition, we leverage on our existing pool of information, paid database and other valid information sources available in public domain.
Usually industry interactions extend to more than 50+ interviews from market participants across the value chain.
Data Collection
After being done with desk research, detailed questionnaire and discussion guide is formulated to initiate primary research with key industry personnel; the discussion aims at collecting key insights, growth perspectives, prevalent market trends and quantitative insights including market size and competition developments. Both of these research approaches help us in arriving at base year numbers and market hypothesis.
Data Validation
In this phase,
Data Analysis and Projection
Data analysis and projections were made based on proprietary research frameworks and statistical analysis, which was further validated from industry participants. These frameworks include Y-o-Y growth projections, macro-economic factor performance, market attractiveness analysis, key financial ratios, and others.
For public companies we capture the data from company website, annual reports, investor presentations, paid databases.While for privately held companies, we try to gather information from the paid databases (like Factiva) and based on the information we gather from databases we estimate revenue for the companies.
In addition, the team tries to establish primary contact with the companies in order to validate the assumptions or to gather quality inputs.
Standard Report Structure
Executive Summary
Market Definition
Macro-economic analysis
Parent Market Analysis
Market Overview
Forecast Factors
Segmental Analysis and Forecast
Regional Analysis
Competition Analysis
Target Audience
Physicians
Surgeons
Pathology In charge
Procurement Manager
Laboratory Technicians
Hospital Accountants
Government Authorities
Key Questions Answered
How the market has performed over the past few years?
What have been the challenges for market participants and how did they overcome them?
How the competitors have performed and what have been their growth strategies?
What is the market potential expected to look like in near future across the globe?
What should be the future course of action?
Where do I currently stand?
Which are the segments, factors, regions offering promising growth potential?
What are the trends in the market and am I ready for them?
Market Taxonomy
Product Type
ELISA-based Tests
RT-PCR based Tests
Dengue IgG/IgM Rapid Test
End User
Hospitals
Diagnostic Centers
Others
Region
APAC
MEA
Read the full report: https://www.reportlinker.com/p05429841
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
View original content:http://www.prnewswire.com/news-releases/global-market-study-on-dengue-testing-asia-pacific-to-hold-dominant-revenue-share-over-2017---2025-300660308.html
SOURCE Reportlinker
A.M. Best Places Credit Ratings of Grange Life Insurance Company Under Review With Developing Implications
Xponential Growth Solutions Launches Plan Sponsor Workshop
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News